1030 Sync Street
About Syneos Health
Why Syneos Health? Join a game-changing global company that is reinventing the way therapies are developed and commercialized. Created through the merger of two industry leading companies - INC Research and inVentiv Health - we bring together more than 21,000 clinical and commercial minds to create better, smarter, faster ways to get biopharmaceutical therapies to patients. Teaming with some of the most talented professionals in the industry, you'll gain exposure and work in a dynamic environment where you'll be supported with comprehensive resources including emerging technologies, data, science and knowledge sharing. Grow your career with a global company committed to shortening the distance from lab to life.
Every aspect of Syneos Health fuels our Biopharmaceutical Acceleration Model -- and unlike traditional CROs and commercialization businesses, here, clinical and commercial are working together to accelerate customer success.
177 articles with Syneos Health
Cel-Sci Wins Breach of Contract Ruling against Clinical Research Organization inVentiv, Now Known as Syneos Health
CEL-SCI Corporation (NYSE American: CVM) announced today that after a four and a half year battle a decision has been delivered by the arbitrator in CEL-SCI's arbitration suit against clinical development giant inVentiv.
Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients
Syneos Health™ and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.
After 35 years at the helm of Parexel International Corporation, co-founder Josef von Rickenbach is stepping down from his role as chief executive officer.
Syneos Health has announced the appointment of Lisa van Capelle as Chief Human Resources Officer.
The company is the the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO.
The word Syneos (pronounced SIN-ee-ohs) communicates the value of synchronizing clinical and commercial capabilities to accelerate customer performance.
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
Participants may access the conference call live via webcast on the Investor Relations section of the INC Research website.
Investigative Sites Honor INC Research/inVentiv Health With 2017 Society For Clinical Research Sites Eagle Award
MEDIAN Technologies And inVentiv Health Announce Strategic Alliance To Provide Best-In-Class Medical Image Analysis And Management Services For Clinical Trials
inVentiv Health Expands Commitment To Elevating Voice Of The Site To Drive Acceleration And Increased Quality Of Trials